EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
- Products
-
- minolira (minocycline hydrochloride) extended-release tablets
- Company
- EPI Health, LLC
- Where it was sold
-
US Nationwide
Nationwide
- Units affected
- 12808 bottles
- About this recall
- minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-101-30.